Vericel Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-25 12:15:44 ET
More on Vericel
- Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Vericel: Growth Plans May Have Run Out Of Gas (Rating Downgrade)
- Vericel expects $276 mln revenue in 2025
- Seeking Alpha’s Quant Rating on Vericel
Read the full article on Seeking Alpha
For further details see:
Vericel Q4 2025 Earnings Preview
Vericel Corporation
NASDAQ: VCEL
VCEL Trading
0.26% G/L:
$32.95 Last:
40,065 Volume:
$33.25 Open:
VCEL Latest News
March 04, 2026 08:00:00 am
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
VCEL Stock Data
$1,790,320,520
46,932,696
0.13%
97
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
